1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Experimental Neoplasms

1,2-bis(3,5-dioxopiperazin-1-yl)ethane has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldman, HD; Lee, HJ; Witiak, DT; Zwilling, BS	1
Maehara, Y; Sugimachi, K; Yoshida, M	1

Other Studies

2 other study(ies) available for 1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Experimental Neoplasms

Article	Year
Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma. Journal of medicinal chemistry, 1978, Volume: 21, Issue:12 Topics: Adenocarcinoma; Animals; Cricetinae; Lung Neoplasms; Male; Mesocricetus; Molecular Conformation; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Structure-Activity Relationship	1978
MST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:12 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Digestive System; Doxorubicin; Female; Humans; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Piperazines; Prodrugs; Razoxane; Survival Analysis; Tumor Cells, Cultured	1999

Article

Year

Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.

Journal of medicinal chemistry, 1978, Volume: 21, Issue:12

Topics: Adenocarcinoma; Animals; Cricetinae; Lung Neoplasms; Male; Mesocricetus; Molecular Conformation; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Structure-Activity Relationship

1978

MST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacy.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:12

Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Digestive System; Doxorubicin; Female; Humans; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Piperazines; Prodrugs; Razoxane; Survival Analysis; Tumor Cells, Cultured

1999